Avita Medical

From WikiMD's WELLNESSPEDIA

Avita Medical is a medical device company that specializes in the design and manufacture of regenerative medicine products. The company's primary product is the Recell System, a device used for skin regeneration in burns and other wounds.

History[edit]

Avita Medical was founded in 2008 in Australia, with the aim of developing innovative, patient-centric treatments for a range of medical conditions. The company's initial focus was on the development of regenerative medicine technologies, which led to the creation of the Recell System.

Recell System[edit]

The Recell System is a medical device that uses a small sample of the patient's own skin to create a suspension of skin cells. This suspension can then be sprayed onto a wound, where it promotes healing and skin regeneration. The Recell System is primarily used for the treatment of burns, but it can also be used for other types of wounds, such as ulcers and surgical wounds.

The Recell System has been approved for use in several countries, including the United States, Australia, and the European Union. It has been shown to reduce the need for skin grafts in burn patients, and to improve healing times and outcomes in a range of wound types.

Research and Development[edit]

Avita Medical is committed to ongoing research and development in the field of regenerative medicine. The company is currently involved in several clinical trials investigating the use of the Recell System in new applications, such as the treatment of vitiligo and scar revision.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.